| Literature DB >> 28399868 |
Ibrahim Jantan1, Khairana Husain2.
Abstract
BACKGROUND: Gynura segetum is used traditionally to treat various ailments related to the immune system, which include cancer, inflammation, rheumatism, diabetes, hypertension, and viral infections but little studies have been carried out to validate their ethnopharmacological aspects. In this study the immunosuppressive effects of G. segetum and its constituents were investigated.Entities:
Keywords: 4,5,4'-Trihydroxychalcone; 8,8'-(Ethene-1,2-diyl)-dinaphtalene-1,4,5-triol; Gynura Segetum; HPLC analysis; Immunosuppressive effects; Rutin
Mesh:
Substances:
Year: 2017 PMID: 28399868 PMCID: PMC5387197 DOI: 10.1186/s12906-017-1726-z
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
NMR spectroscopic data (500 MHz, MeOD) for compound 3 (δ in ppm)
| Position | δC | δH, multiplicity | HSQC | HMBC |
|---|---|---|---|---|
| 1 | 107.7 | - | - | - |
| 2 | 120.4 | 8.04, d (7.0) | C-2, H-2 | C-β, C-4 |
| 3 | 111.1 | 7.35, d (8.0) | C-3, H-3 | C-2, C-5 |
| 4 | 136.5 | - | - | - |
| 5 | 125.9 | - | - | - |
| 6 | 131.4 | 7.85, s | C-6, H-6 | C-1, C-5, C-4 |
| 1’ | 124 | - | - | - |
| 2’ | 131 | 7.78, d (8.0) | C-2’, H-2’ | C-3’, C-4’ |
| 3’ | 113.9 | 6.72, d (8.5) | C-3’, H-3’ | C-1’, C-4’ |
| 4’ | 160.6 | - | - | - |
| 5’ | 113.9 | 6.72, d (8.5) | C-5’, H-5’ | C-1’, C-4’ |
| 6’ | 131.9 | 7.78, d (8.0) | C-6’, H-6’ | C-5’, C-4’ |
| C = O | 168.1 | - | - | - |
| α | 120.5 | 7.09, d (7.5) | C-α, H-α | C-2, C-5 |
| β | 121.7 | 7.10, d (7.5) | C-β, H-β | C-3, C-4 |
Fig. 1Structures of new compounds isolated from Gynura segetum
NMR spectroscopic data (500 MHz, MeOD) for compound 4 (δ in ppm)
| Position | δC | δH, multiplicity | HSQC | HMBC | NOESY |
|---|---|---|---|---|---|
| 1 | 159.2 | - | - | - | - |
| 2 | 115.3 | 6.78, | C-2 | - | H-3 |
| 3 | 131.4 | 7.86, | C-3 | C-4 |
|
| 4 | 161.4 | - | - | - | - |
| 5 | 122.9 | - | - | - | - |
| 6 | 115.3 | 6.78, | C-6 | C-5, C-8 | H-7 |
| 7 | 129.3 | 7.42, | C-7 | C-1 | H-6, H- β |
| 8 | 126.3 | - | - | - | - |
| 9 | 114.3 | - | - | - | - |
| 10 | 114.3 | - | - | - | - |
| 1’ | 171.2 | - | - | - | - |
| 2’ | 115.3 | 6.78, | C-2’ | - | H-3’ |
| 3’ | 131.4 | 7.86, | C-3’ | C-4’ | - |
| 4’ | 169.8 | - | - | - | - |
| 5’ | 130.8 | - | - | - | - |
| 6’ | 115.3 | 6.78, | C-6’ | - | H-7’ |
| 7’ | 129.3 | 7.42, | C-7’ | C- α | H-6’ |
| 8’ | 128.3 | - | - | - | - |
| 9’ | 114.3 | - | - | - | - |
| 10’ | 114.4 | - | - | - | - |
| β | 116.6 | 6.29, | - | C-8 | H-7 |
| α | 143.5 | 7.51, | - | C-7’, C-1’ | - |
Fig. 2Representative HPLC chromatograms of (a) gallic acid, RT 3.078 min (b) rutin, RT 5.161 min (c) Gynura segetum methanol extract detected at the wavelength of 254 nm
IC50 values (μg/mL) of chemotaxis, lymphocytes proliferation, NO and ROS inhibitory activities of G. segetum extract and its compounds on phagocytes (Mean ± SEM, n = 3)
| Samples | Chemotaxis | Chemiluminescence | Nitric oxide | Lymph. Proliferation | Cytokines | ||||
|---|---|---|---|---|---|---|---|---|---|
| Zymosan | PMA | ||||||||
| Whole Blood | PMNs | Whole Blood | PMNs | TNF-α | IL-1β | ||||
|
| 2.03 ± 0.77 | 2.93 ± 1.62 | 2.63 ± 0.89 | 0.18 ± 0.12 | 1.41 ± 0.63 | 0.16 ± 0.03 | 3.25 ± 1.08 | 16.20 ± 3.94 | 2.72 ± 1.84 |
| Rutin | 2.53 ± 0.97 | 1.12 ± 2.32 | 0.08 ± 0.01 | 0.15 ± 0.34 | 0.05 ± 0.02 | 0.69 ± 1.98 | 2.26 ± 1.27 | 10.36 ± 6.98 | 6.95 ± 1.47 |
| (4.14 ± 1.09) | (1.95 ± 0.23) | (0.13 ± 0.01) | (0.25 ± 0.62) | (0.08 ± 0.02) | (1.13 ± 0.03) | (3.72 ± 2.08) | (16.96 ± 11.43) | (11.37 ± 2.41) | |
| Gallic Acid | 1.40 ± 0.02 | 1.70 ± 0.03 | 0.43 ± 1.02 | 0.87 ± 0.12 | 0.48 ± 0.01 | 4.13 ± 3.80 | 1.43 ± 0.65 | 13.92 ± 4.65 | 35.28 ± 3.62 |
| (8.22 ± 0.15) | (9.99 ± 0.12) | (2.53 ± 0.10) | (5.11 ± 0.15) | (2.82 ± 0.15) | (24.17 ± 12.50) | (8.43 ± 3.83) | (81.82 ± 1.87) | (207.38 ± 1.35) | |
| 4,5,4’-Trihydroxychalcone ( | 1.29 ± 0.89 | 4.92 ± 1.88 | 0.47 ± 0.03 | 5.14 ± 3.5 | 1.49 ± 0.38 | 0.39 ± 0.18 | 0.76 ± 0.36 | 18.87 ± 0.04 | 1.72 ± 0.77 |
| (5.04 ± 018) | (19.20 ± 3.55) | (1.84 ± 0.13) | (20.03 ± 6.04) | (5.86 ± 1.51) | (1.52 ± 0.73) | (2.96 ± 1.39) | (73.51 ± 0.14) | (6.69 ± 3.01) | |
| Naphthelenetriol, (1,2-ethenedyl) ( | 0.84 ± 0.09 | 1.10 ± 1.12 | 0.02 ± 0.01 | 1.79 ± 0.80 | 0.05 ± 0.02 | 0.06 ± 0.03 | 4.59 ± 0.25 | 25.51 ± 11.12 | 16.76 ± 8.39 |
| (2.22 ± 0.33) | (2.93 ± 1.40) | (0.05 ± 0.02) | (4.77 ± 2.13) | (0.13 ± 0.08) | (0.15 ± 0.06) | (12.22 ± 0.67) | (67.84 ± 29.57) | (44.58 ± 22.33) | |
| Ibuprofen | 1.42 ± 0.14 | – | – | – | – | – | – | – | – |
| (6.80 ± 0.10) | |||||||||
| Aspirin | – | 2.21 ± 0.79 | 1.91 ± 0.24 | 0.17 ± 0.01 | 0.14 ± 0.09 | – | – | – | – |
| (12.21 ± 1.10) | (10.52 ± 2.11) | (0.94 ± 0.05) | (0.77 ± 0.16) | ||||||
| Prednisolone | – | – | – | – | – | – | 0.038 ± 0.02 | – | – |
| (0.098 ± 0.066) | |||||||||
| Dexamethasone | – | – | – | – | – | 0.0097 ± 0.002 | – | 0.77 ± 0.27 | 0.26 ± 1.02 |
| (0.025 ± 0.017) | (1.96 ± 0.44) | (0.67 ± 1.32) | |||||||
IC50 values in μg/ml are in parentheses
Percentage of CD18 expression activity (%) of neutrophils and monocytes at various concentrations of G. segetum extract and its compounds (Mean ± SEM, n = 3)
| Sample (μg/mL) | Neutrophils | Monocytes | ||||||
|---|---|---|---|---|---|---|---|---|
| 100 | 50 | 6.25 | 3.125 | 100 | 50 | 6.25 | 3.125 | |
|
| 82.1 ± 11.9 | 90.0 ± 5.2 | 78.0 ± 8.5 | 84.8 ± 7.4 | ||||
| Rutin | 88.75 ± 0.49 | 99.35 ± 0.64 | 91.60 ± 1.84 | 91.20 ± 1.56 | ||||
| Gallic Acid | 81.33 ± 1.80 | 88.77 ± .41 | 68.60 ± 1.20 | 76.50 ± 2.18 | ||||
| 4,5,4’-trihydroxy chalcone | 94.60 ± 0.42 | 93.80 ± .42 | 96.25 ± 2.33 | 97.60 ± 0.85 | ||||
| 8,8’-(ethene-1,2-diyl)-dinaphtalene-1,4,5-triol ( | 97.80 ± 2.30 | 93.10 ± 4.20 | 79.90 ± 4.50 | 92.30 ± 5.60 | ||||
Fig. 3Representation of E.coli engulfment by neutrophils (1) and monocytes (2). a positive control b negative control, c Gynura segetum extract d Rutin e Gallic acid f 4,5,4’-Trihydroxychalcone (3) g 8,8’-(ethene-1,2-diyl)-dinaphtalene-1,4,5-triol (4)